Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body. They propose that therapies targeting this process could be developed to halt or prevent metastasis and reduce breast cancer deaths. Natural killer (NK) […]
Cancer Matters with Dr Bill Nelson – Preventing the Spread of COVID-19
Posted by | podcast, ResearchIn the latest Cancer Matters podcast, Dr Bill Nelson speaks with Dr Bert Vogelstein about shifting his work as a cancer researcher to detecting and preventing the spread of COVID-19.
Radiation Therapy Associated With Worse Outcomes in One Type of Brain Tumor
Posted by | Research, treatmentIn a research study published online June 24 in the journal Clinical Neurology and Neurosurgery, the research team found that routine radiation treatment after surgery for a rare and slow-growing type of brain tumor called pleomorphic xanthoastrocytoma, or PXAs, was associated with markedly worse overall survival. The researchers reviewed 550 PXA patients from the National […]
Regulator of Neurofibromatosis Type 1-Caused Brain Tumors Uncovered
Posted by | ResearchA new research study published June 20 in Neuropathology and Applied Neurobiology found key biological differences between aggressive and more indolent, less harmful brain tumors that develop in neurofibromatosis type 1 (NF1) patients. NF1 is a genetic disorder that can predispose those affected to benign and cancerous nervous system tumors. “These findings may lead to […]
Immune Cells Hampered When Fighting Soft Tissue and Bone Sarcomas
Posted by | Issues & Perspectives, treatmentResearchers at the Johns Hopkins Kimmel Cancer Center are studying the immune system to find what does and doesn't work to better fight soft tissue & bone cancer. “The basis of successful immunotherapy lies in the ability of the immune system to recognize cancer as foreign and attack, and is dependent on genetics, host and […]
Cancer Matters with Dr Bill Nelson – Cancer Disparities and COVID-19
Posted by | Issues & Perspectives, podcastIn this Cancer Matters podcast, Dr Bill Nelson and Dr Otis Brawley discuss why the poor and disadvantaged that are already struggling with a cancer diagnosis are also more susceptible to COVID-19.
Cancer Matters with Dr. Bill Nelson – Re-Animating Cancer Surgery
Posted by | podcastIn this Cancer Matters podcast, Dr Bill Nelson and Dr Ashwani Rajput, the Director of the Kimmel Cancer Center in the National Capital Region, discuss how the Johns Hopkins Health System will deal with a backlog of cancer surgeries that were delayed by COVID-19.
On Target with Dr. Akila Viswanathan – HPV Related Head and Neck Cancers
Posted by | podcastIn this On Target podcast, Dr Akila Viswanathan and Dr Ana Kiess discuss the treatment of HPV-related head and heck cancers and the future of radiopharmaceuticals.
Cancer Doctors Call for More Training in Palliative Care and Delivery of ‘Bad News’
Posted by | palliative careOncologists who practice and teach at the Johns Hopkins Kimmel Cancer Center are calling on medical oncology training programs to invest substantially more time educating physicians about palliative care and how to talk to patients about “bad news.” Click here to read more
Clinical Trial of Blood Pressure Drug Aimed at Preventing Lethal Complication of COVID-19
Posted by | ResearchResearchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection. Read the full news release